Viewing nowCombinationUnivis D Tablet
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
Korea Union Pharmaceutical Co., Ltd.

MFDS item code 201605101 · Approved 2016.08.25
Treatment of gastrointestinal disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.); prevention of Mendelson's syndrome
This medication is used to treat ulcers that occur in the stomach and duodenum, gastritis, and conditions characterized by excessive gastric acid such as Zollinger-Ellison syndrome. It also alleviates symptoms of gastroesophageal reflux disease and is administered to prevent Mendelson's syndrome prior to surgery. After surgery, it is effective in preventing the formation of ulcers and treating gastric and duodenal ulcers that occur due to the use of nonsteroidal anti-inflammatory drugs (NSAIDs). It is used to improve various gastric diseases and inflammation.
Usually, administer 1 tablet orally twice daily, in the morning and before bedtime, regardless of meals. Gastric and duodenal ulcers: Administer 1 tablet twice daily or 2 tablets once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for prevention of gastric or duodenal ulcers during long-term NSAID therapy. Diseases caused by NSAID administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing time may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term therapy with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. Reflux esophagitis: For 8 weeks, administer 1 tablet twice daily or 2 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. Zollinger-Ellison syndrome: Initiate treatment with an initial dose of 1 tablet 3 times daily, and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions: When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. Preanesthetic medication (prevention of Mendelson syndrome): Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.
This medication should not be used in certain patients. For example, it is not administered to patients undergoing dialysis or those who have had an allergic reaction to this medication or its components, as well as patients with a history of acute porphyria. Additionally, it should not be used in patients with poor kidney function, those who have had upper gastrointestinal surgery, pregnant women or women who may become pregnant, premature infants and newborns, and patients following a diet that restricts potassium intake. Care should be taken when administering this medication to patients with weakened liver function, a history of drug allergies, elderly patients, and those with a past history of kidney issues. In particular, there is a risk of gastrointestinal bleeding when taken with NSAIDs, so their condition should be regularly monitored. This medication can mask symptoms of gastric cancer, so gastric ulcer patients or those over middle age with new dyspeptic symptoms should confirm that it is not a malignant disease before use. Patients with Helicobacter pylori-positive gastric or duodenal ulcers require bacterial eradication therapy. Caution is necessary for severely ill patients in intensive care, patients with hypophosphatemia, and those with swallowing difficulties, as this medication can cause various side effects in some patients, including severe allergic reactions, blood abnormalities, liver dysfunction, arrhythmias, gastrointestinal symptoms, neurological disturbances, muscle pain, skin rashes. If any abnormal symptoms occur, administration should be stopped immediately and medical consultation should be sought. Long-term use should be avoided, and if there is no therapeutic effect, switching to another medication is necessary. Regular blood tests and liver and kidney function tests are important. Dizziness or drowsiness may occur while taking this medication, so driving or operating hazardous machinery should be avoided. There may be drug interactions, so it is imperative to inform healthcare professionals of any other medications being taken. This is especially true when taken with anticoagulants, antibiotics, or anticonvulsants. It is safest for women who are pregnant or breastfeeding to avoid this medication, and its safety in pediatric patients has not been established, hence it is not recommended. In case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and dialysis can be used to remove the drug if needed. This medication reduces gastric acid secretion which may promote bacterial growth in the gastrointestinal tract, so regular examinations, including ophthalmologic checks, are necessary during long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This will help safely maintain the medication's effectiveness.
Pale green oblong film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRanitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
Korea Union Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.